Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Morningstar (MORN) Asset Writedowns and Impairment (2016 - 2025)

Historic Asset Writedowns and Impairment for Morningstar (MORN) over the last 17 years, with Q3 2025 value amounting to $600000.0.

  • Morningstar's Asset Writedowns and Impairment fell 6666.67% to $600000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $4.3 million, marking a year-over-year decrease of 4625.0%. This contributed to the annual value of $8.1 million for FY2024, which is 5283.02% up from last year.
  • As of Q3 2025, Morningstar's Asset Writedowns and Impairment stood at $600000.0, which was down 6666.67% from -$600000.0 recorded in Q2 2025.
  • In the past 5 years, Morningstar's Asset Writedowns and Impairment registered a high of $3.1 million during Q2 2024, and its lowest value of -$600000.0 during Q2 2025.
  • Moreover, its 5-year median value for Asset Writedowns and Impairment was $1.2 million (2021), whereas its average is $1.2 million.
  • In the last 5 years, Morningstar's Asset Writedowns and Impairment skyrocketed by 180000.0% in 2022 and then crashed by 11935.48% in 2025.
  • Quarter analysis of 5 years shows Morningstar's Asset Writedowns and Impairment stood at -$100000.0 in 2021, then soared by 1800.0% to $1.7 million in 2022, then changed by 0.0% to $1.7 million in 2023, then rose by 5.88% to $1.8 million in 2024, then tumbled by 66.67% to $600000.0 in 2025.
  • Its last three reported values are $600000.0 in Q3 2025, -$600000.0 for Q2 2025, and $2.5 million during Q1 2025.